354 related articles for article (PubMed ID: 22123068)
1. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
[TBL] [Abstract][Full Text] [Related]
3. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
4. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
5. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic effect of KH902 on retinal neovascularization.
Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
10. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
[TBL] [Abstract][Full Text] [Related]
11. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
14. Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
[TBL] [Abstract][Full Text] [Related]
16. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
[No Abstract] [Full Text] [Related]
18. Rifampicin inhibits the retinal neovascularization in vitro and in vivo.
Chikaraishi Y; Matsunaga N; Shimazawa M; Hara H
Exp Eye Res; 2008 Jan; 86(1):131-7. PubMed ID: 18031740
[TBL] [Abstract][Full Text] [Related]
19. Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β.
Zhou L; Sun X; Huang Z; Zhou T; Zhu X; Liu Y; Wang J; Cheng B; Li M; He C; Liu X
Cell Physiol Biochem; 2018; 48(1):263-273. PubMed ID: 30007969
[TBL] [Abstract][Full Text] [Related]
20. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
